New dimensions in Hirsutism.
The following is a review of a satellite symposium held at the British Medical Laser Association Meeting, in November 2005. Prof. V.A. Randall gave a comprehensive overview of hormones and hair growth, followed by an in-depth discussion of hirsutism, the therapeutic options, treatment and trends, by Dr. S. Lanigan. Dr. I. Hamzavi concluded the symposium with a presentation of the latest work on eflornithine in combination with laser hair removal. Data were reproduced with the speakers' permission.
Randall
V A
VA
Department of Biomedical Sciences, University of Bradford, Bradford, B7 1DP, UK. V.A.Randall@Bradford.ac.uk
Lanigan
S
S
Hamzavi
I
I
Chamberlain James
L
L
D000728:Androgens / Q000378:metabolism; D042944:Cholestenone 5 alpha-Reductase / Q000378:metabolism; D000518:Eflornithine / Q000627:therapeutic use; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D005260:Female; D006628:Hirsutism / Q000378:metabolism / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D028022:Low-Level Light Therapy / Q000009:adverse effects; D008297:Male; D012727:Sex Characteristics; D012737:Sex Factors; D013739:Testosterone / Q000378:metabolism
D000728:Androgens; D004791:Enzyme Inhibitors; D013739:Testosterone; D042944:Cholestenone 5 alpha-Reductase; D000518:Eflornithine